These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 22488107

  • 1. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease.
    Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N, Embury SH.
    Am J Hematol; 2012 May; 87(5):536-9. PubMed ID: 22488107
    [Abstract] [Full Text] [Related]

  • 2. Cellular adhesion and the endothelium: P-selectin.
    Kutlar A, Embury SH.
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):323-39. PubMed ID: 24589269
    [Abstract] [Full Text] [Related]

  • 3. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD, Chen C, Nguyen J, Abdulla F, Nguyen P, Nguyen M, Okeley NM, Benjamin DR, Senter PD, Vercellotti GM.
    PLoS One; 2015 Apr; 10(2):e0117772. PubMed ID: 25706118
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Normal sublingual microcirculation during painful crisis in sickle cell disease.
    van Beers EJ, Goedhart PT, Unger M, Biemond BJ, Ince C.
    Microvasc Res; 2008 May; 76(1):57-60. PubMed ID: 18423765
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.
    Marshall JL, Wellstein A, Rae J, DeLap RJ, Phipps K, Hanfelt J, Yunmbam MK, Sun JX, Duchin KL, Hawkins MJ.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2347-54. PubMed ID: 9815633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N, Fattori A, Saad ST, Costa FF.
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [Abstract] [Full Text] [Related]

  • 10. The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo.
    Embury SH, Matsui NM, Ramanujam S, Mayadas TN, Noguchi CT, Diwan BA, Mohandas N, Cheung AT.
    Blood; 2004 Nov 15; 104(10):3378-85. PubMed ID: 15271798
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thrombogenesis in sickle cell disease.
    Tomer A, Harker LA, Kasey S, Eckman JR.
    J Lab Clin Med; 2001 Jun 15; 137(6):398-407. PubMed ID: 11385360
    [Abstract] [Full Text] [Related]

  • 20. Modulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative.
    Alshaiban A, Muralidharan-Chari V, Nepo A, Mousa SA.
    Clin Appl Thromb Hemost; 2016 Apr 15; 22(3):230-8. PubMed ID: 25601897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.